feed,title,long_url,short_url
Benzinga,McKesson Boosts FY23 Outlook Backed By Strong Contribution From COVID-19 Drugs,https://benzinga.com/news/earnings/22/08/28349027/mckesson-boosts-fy23-outlook-backed-by-strong-contribution-from-covid-19-drugs,https://bit.ly/3zUdNQO
Benzinga,EPAM Clocks 36% Revenue Growth In Q2; Beats Consensus Handsomely,https://benzinga.com/news/earnings/22/08/28350535/epam-clocks-36-revenue-growth-in-q2-squashes-consensus,https://bit.ly/3zUdNjM
